Lycodoline is primarily investigated for its biological activity, particularly in the field of pharmacology. It exhibits potential neuroprotective and cognitive-enhancing properties, making it a subject of interest in the development of treatments for neurodegenerative disorders such as Alzheimer's disease. Research suggests that Lycodoline may interact with central nervous system receptors, influencing cholinergic transmission, which plays a key role in memory and learning processes. Additionally, it has shown mild acetylcholinesterase inhibitory effects, a mechanism shared by some approved drugs for dementia. While still in the experimental stage, Lycodoline serves as a lead compound for designing novel therapeutic agents targeting cognitive impairment. Its natural origin and structural complexity also make it valuable in studies exploring structure-activity relationships in alkaloid chemistry.